All but one patient (97.4%) in our series had systemic activity at diagnosis (global ESSDAI score ≥ 1) and was diagnosed with SS according to the presence of SSA autoantibodies and LSG biopsy findings, and the last patient’s diagnosis of SS was made according to the proposed juvenile pSS criteria. Here, CALR is linked to synovial sarcoma.